THE European Medicines Agency
has endorsed a recommendation
that oral medications containing
almitrine should be suspended
across the EU from next month.
The move follows a safety review
of oral almitrine initiated by the
French medicines agency, which
concluded that the available
evidence did not support the use
of the medicine in the current
management of COPD.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Jun 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Jun 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.